Pharmaceutical companies are understandably eager to enter a Chinese
domestic market that was estimated by the Boston Consulting Group to
be worth US$13 billion last year, and growing fast. But they are
tantalized by one opportunity above all: the prospect that the
nation's traditional medicine might contain a number of potentially
profitable compounds hidden somewhere in its arcane array of potions
and herbal mixtures.
對製藥業出現的進軍自然藥物的勢頭當頭棒喝？其實，這是英國傳統式的傲慢和偏見！我長期生活在英國，對此深有感觸。英國人的沒落就起因於這種驕橫式的保守！

The task of finding these elusive gems has been approached in a
typically reductionist manner, with researchers seeking single
compounds that might have a role in treating specific diseases.
Sometimes this has been successful: artemisinin, for example, which is
currently the most effective treatment for malaria, was fished out of
a herbal treatment for fevers. But such success stories have been few
and far between.

傳統的還原論方法論確實解決不了系統論的問題！

So if traditional Chinese medicine is so great, why hasn't the
qualitative study of its outcomes opened the door to a flood of cures?
The most obvious answer is that it actually has little to offer: it is
largely just pseudoscience, with no rational mechanism of action for
most of its therapies. Advocates respond by claiming that researchers
are missing aspects of the art, notably the interactions between
different ingredients in traditional therapies.

如果說中醫藥缺乏理性思維，中醫藥缺乏理性機制純屬一派胡言！pseudoscience確實是一種知識類型，就像心理學等都屬於這一類。pseudoscience不能就說是偽科學，如果是那麼屬於偽科學的絕不只是中國醫藥學，包括心理學等都是。